Sign in

CIK 0001644963

  • Non-accelerated filer
  • Smaller reporting company

AVENUE THERAPEUTICS, INC.

Sign in to watch
Ticker
ATXI
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474113275
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
  1. 4 Open-market sale Chief Financial Officer sold 3,840 shares at $12.13 ($46,579)
  2. 4 Grant or award Director acquired 10,000 shares (grant or award)
  3. 4 Grant or award Director acquired 10,000 shares (grant or award)
  4. 4 Open-market buy Chief Financial Officer bought 3,389 shares at an average $7.96 ($26,982)
  5. 4 Open-market buy Director bought 2,561 shares at an average $8.23 ($21,086)
  6. 4 Open-market buy Chief Financial Officer bought 1,200 shares at $9.09 ($10,908)
  7. 4 Open-market buy Director bought 10,000 shares at $9.31 ($93,100)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Director bought 16,000 shares at $6.27 ($100,320)
  12. 4 Grant or award Director acquired 10,000 shares (grant or award)
  13. 4 Grant or award Director acquired 10,000 shares (grant or award)
  14. 4 Open-market sale Chief Financial Officer sold 4,688 shares at an average $5.59 ($26,204)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy Director bought 5,000 shares at an average $5.86 ($29,300)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy Director bought 1,000 shares at $4.52 ($4,520)

Page 3 of 5 · 96 filings